Cargando…

Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations From Southern China

Human adenoviruses type 4 (HAdV4) and 7 (HAdV7) are two major respiratory pathogens and sporadically cause outbreaks of acute respiratory diseases. The neutralizing antibody (nAb) response to these two adenoviruses in civilian populations, which is important for dissecting previous circulations and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Xianmiao, Xiao, Lijun, Zheng, Xuehua, Wang, Jinlin, Shu, Tao, Feng, Ying, Liu, Xinglong, Su, Wan, Wang, Qian, Li, Chufang, Chen, Ling, Feng, Liqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295555/ https://www.ncbi.nlm.nih.gov/pubmed/30619131 http://dx.doi.org/10.3389/fmicb.2018.03040

Ejemplares similares

Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China
por: Zheng, Xuehua, et al.
Publicado: (2017)

Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China
por: Yi, Haisu, et al.
Publicado: (2022)

Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma
por: Zhang, Yiling, et al.
Publicado: (2018)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
por: Zhao, Hua, et al.
Publicado: (2018)

Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines
por: Francisco, Abialbon G., et al.
Publicado: (2023)

Emergence and characterization of a putative novel human adenovirus recombinant HAdV-C104 causing pneumonia in Southern China
por: Ji, Tianxing, et al.
Publicado: (2021)

Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
por: Wang, Xiang, et al.
Publicado: (2014)

Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders
por: Klann, Patrick Julian, et al.
Publicado: (2022)

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein
por: Liu, Xinglong, et al.
Publicado: (2018)

An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques
por: Feng, Yupeng, et al.
Publicado: (2018)

Seroprevalence of neutralizing antibodies to human mastadenovirus serotypes 3 and 7 in healthy children from guangdong province
por: Kuang, Lu, et al.
Publicado: (2023)

Seroprevalence of neutralizing antibodies against human adenovirus type 55 in the South Korean military, 2018-2019
por: Park, So Yun, et al.
Publicado: (2020)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

The infectivity of progeny adenovirus in the presence of neutralizing antibody
por: Hirai, Takamasa, et al.
Publicado: (2021)

Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China
por: Tian, Xingui, et al.
Publicado: (2020)

Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus
por: Zeng, Qin, et al.
Publicado: (2012)

Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A
por: Stanford, Sophia, et al.
Publicado: (2019)

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
por: Feng, Liqiang, et al.
Publicado: (2020)

An Efficient and Rapid Assay for Detecting Neutralizing Antibodies Against Serotype 4 Fowl Adenovirus
por: Guo, Yiwen, et al.
Publicado: (2022)

Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam
por: Kuo, Fang-Lin, et al.
Publicado: (2020)

Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases
por: Meng, Weixu, et al.
Publicado: (2013)

A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability
por: Chen, Lei, et al.
Publicado: (2023)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
por: Kashiwakura, Yuji, et al.
Publicado: (2022)

Regulation of SIV Antigen-Specific CD4+ T Cellular Immunity via Autophagosome-Mediated MHC II Molecule-Targeting Antigen Presentation in Mice
por: Jin, Yi, et al.
Publicado: (2014)

Seroprevalence of Chikungunya in Southern Odisha
por: Mohanty, Indrani, et al.
Publicado: (2013)

Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
por: Weaver, Eric A., et al.
Publicado: (2013)

Identification of Two Novel Linear Neutralizing Epitopes within the Hexon Protein of Canine Adenovirus Using Monoclonal Antibodies
por: Wang, Shujie, et al.
Publicado: (2021)

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients
por: Yan, Qihong, et al.
Publicado: (2021)

Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012
por: Yamanaka, Atsushi, et al.
Publicado: (2021)

Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies
por: Khalil, Ibrahim R., et al.
Publicado: (2018)

Human innate lymphoid cell activation by adenoviruses is modified by host defense proteins and neutralizing antibodies
por: Paris, Océane, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
por: Napolitano, Francesco, et al.
Publicado: (2021)

Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fcγ Receptor-Dependent and -Independent Pathways
por: Yu, Lei, et al.
Publicado: (2021)

Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population
por: Katz, Itai, et al.
Publicado: (2020)

A Novel Recombinant Peste des Petits Ruminants-Canine Adenovirus Vaccine Elicits Long-Lasting Neutralizing Antibody Response against PPR in Goats
por: Qin, Junling, et al.
Publicado: (2012)

Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran
por: Asaei, Sadaf, et al.
Publicado: (2015)

Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji
por: Henderson, Alasdair D, et al.
Publicado: (2020)

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
por: Tyson, Grace B., et al.
Publicado: (2023)

Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs
por: Bergmann, Michèle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_30bgbnb15rdpm28js2ju7gqgb4